Advertisement Production of Monoclonal or Recombinant Antibodies - Pharmaceutical Business review

Advertisement

Pharmaceutical Business review is using cookies

ContinueLearn More
Close
close icon

Glycotope

GlycoEngineering and Immunotherapeutics

More info about Glycotope

Production of Monoclonal or Recombinant Antibodies

Glycotope

Production of monoclonal antibodies and antibody derivates can be carried out using a variety of mammalian cell lines, ranging from the widely-used CHO-cells to our proprietary human cells, ensuring a glyco-optimisation.

Systems used are either stainless steel fermenters, ranging from ten to 200 litres, or single use bioreactors, ranging from 20 to 1,000 litres. Upon our customers’ request, these fermenters can be run in fed-batch, or perfusion mode.

Click here for more information.

Quick Contact Production of Monoclonal or Recombinant Antibodies